Vik Bajaj, managing director at venture capitalist firm Foresite Capital and CEO of Foresite Labs, which focuses on transforming healthcare through data-driven solutions, sat down with MobiHealthNews ...

Pancreatic cancer is notoriously hard to treat, often resisting therapies that target its most common mutations. Researchers ...

Pitavastatin, a cholesterol lowering drug, slashes chemotherapy resistance in breast cancer by obstructing a specific protein ...

Novel Concepts Medical is proud to announce breakthrough results from its labs in Israel showing that its plant-based formula resulted in over 99% decrease in cell viability of breast cancer cells and ...

Researchers at CSH Laboratory identified an oncogenic SRSF1–AURKA–MYC circuit driving pancreatic ductal adenocarcinoma.

Antioxidants have long been regarded as key players in protecting cells and maintaining health, but a research team led by Professor Wen-Ching Wang (王雯靜) from the Department of Life Science at ...

Triple-negative breast cancer (TNBC) is among the most aggressive types of breast cancer, lacking estrogen, progesterone, and ...

Selenium in renal cell carcinoma showed context dependent redox effects, lowering reactive oxygen species in baseline ...

Impact of multimodal, multidisciplinary care on clinical outcomes in patients with breast cancer and leptomeningeal carcinomatosis. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I ...

The study focused on two particularly hard-to-treat breast cancer subtypes: triple-negative breast cancer and HER2-enriched breast cancer. Both forms are known for their resistance to conventional ...